The Unintended Consequences Of The Swiss-EU Medtech MRA Failure
Executive Summary
Manufacturers will have to adjust to new medtech labeling rules to enter the Swiss market, but how far will patients relying on imports of low-risk medical devices be affected when the Swiss-EU MRA transition period ends?
You may also be interested in...
Swissdamed Devices Database Will Mirror Eudamed
Outside the EU and no longer enjoying an MRA with the bloc, Switzerland has had to develop its own medical device database, work on which will continue into next year.
Healthtech Responds To Providers’ Productivity, Workflow And Sustainability Concerns
Healthtech innovators are being asked by users and clinicians how technology solutions can increase health system efficiency and respond to concerns over staff shortages. Royal Philips’ Bert van Meurs fielded these questions at ECR 2024.
Healthtech Responds To Providers’ Productivity, Workflow And Sustainability Concerns
Healthtech innovators are being asked by users and clinicians how technology solutions can increase health system efficiency and respond to concerns over staff shortages. Royal Philips’ Bert van Meurs fielded these questions at ECR 2024.